Sigrid Therapeutics

Sundbyberg, Sweden · Founded 2014 · Privately Held (backing)

Operator of a clinical-stage biotechnology company intended to develop a new class of therapies to prevent and treat lifestyle diseases. Sigrid Therapeutics is based in Sundbyberg, Sweden and was founded in 2014. Its last reported valuation was $40.5 million in Oct 2023. It has raised $20.9 million.

Last reported valuation
$40.5M
Oct 2026
Priced at
—
Total raised
$20.9M
Last round
—

Who backs Sigrid Therapeutics?

16 investors
InvestorType
Almi InvestVenture capital
Joyance PartnersVenture capital
European Regional Development Fund (Brandenburg)Other
Mattsson FamilyFamily office
The Hans and Barbara BergströmFamily office
3T Invest—
Alsteron—
Axilium Holding—
Crosslight Partners—
DRIVE ( KI Innovations Business Incubator)—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Sigrid Therapeutics investors

16 investors are on record for Sigrid Therapeutics, including Almi Invest, Joyance Partners, European Regional Development Fund (Brandenburg) and Mattsson Family.

Free account
More of Sigrid Therapeutics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Sigrid Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Sigrid Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View